Orange County, CA, Jul 16, 2026, ZEX PR WIRE — Innovation creates possibility. Strong leadership turns that possibility into lasting value. Throughout her career, Lisa Doverspike has seen innovation open doors to growth and value creation when it is supported by financial discipline, thoughtful execution, and sound governance. By evaluating opportunities carefully, investing with purpose, and executing with discipline, leaders position their organizations to create lasting value. Years of working across family enterprises, commercial real estate, private equity, digital infrastructure, healthcare, and philanthropy have reinforced one lesson for Lisa. Successful organizations balance optimism with…

Read More

Former marketing professional, executive recruiter, and commissioned Stephen Minister Kendra Stearns Drozd is encouraging people to slow down, listen first, and rethink what meaningful support really looks like. South Carolina, USA, Jul 16, 2026, ZEX PR WIRE — Advice is easy to give. Listening takes more time, more patience, and more intention. Kendra Stearns Drozd believes that the difference matters, especially when someone is going through one of the most difficult seasons of their life. Drawing on decades of experience in advertising, executive recruiting, motherhood, and more than a decade as a…

Read More

Broker confirms UAE and Mauritius licences cover distinct parts of its business, while independent reviews show high customer approval Dubai, UAE, 15th July 2026 — GivTrade, a multi-jurisdiction forex and CFD broker, today set out a clear picture of its regulatory structure and shared independently verified customer feedback data, as the company seeks to give prospective clients a transparent view of how its licensing and service quality compare across the industry. Is GivTrade’s regulatory standing complex? No, not all. In the United Arab Emirates, GivTrade Financial Services L.L.C S.O.C holds…

Read More

New York, NY, July 15th, 2026, FinanceWire EdWealth (edwealth.ai) today announced the launch of Ed, an always-on agentic AI financial coach built for the modern middle class. Money decisions are life decisions: where to live, how to care for family, what future to imagine. And they have become too complex, too fragmented, and too important to keep making half-blind. The wealthy have dedicated financial teams of analysts, tax professionals, and family-office operators helping them decide the best move. Most people do not. Nearly six in ten American adults never turn…

Read More

New York, NY, July 15th, 2026, FinanceWire EdWealth (edwealth.ai) today announced the launch of Ed, an always-on agentic AI financial coach built for the modern middle class. Money decisions are life decisions: where to live, how to care for family, what future to imagine. And they have become too complex, too fragmented, and too important to keep making half-blind. The wealthy have dedicated financial teams of analysts, tax professionals, and family-office operators helping them decide the best move. Most people do not. Nearly six in ten American adults never turn…

Read More

TCL expanded its smart home portfolio with the official launch of a premium fifty-two inch solid wood ceiling fan on Amazon, engineered to provide aerodynamic energy efficiency for year-round residential ventilation. Los Angeles, California, United States, 15th Jul 2026 — TCL, a global pioneer in consumer electronics and home technology, today announced the official availability of its latest climate control development on Amazon, the TCL 52-Inch Solid Wood Ceiling Fan with Light and Remote. This corporate expansion underscores the commitment of the brand to delivering advanced home engineering that balances…

Read More

New York, United States, July 15th, 2026, FinanceWire Atlas Healthcare Fund managed by VST Capital, today highlighted a series of early conviction investment decisions that have defined its track record since launch — none more striking than its position in Eli Lilly and Company, entered at approximately $350 per share in 2020, years before GLP-1 receptor agonists became the most consequential pharmaceutical story of the decade. Eli Lilly now trades above $1,200, a gain of more than 246% from the fund’s entry point. At the time of purchase, Lilly’s tirzepatide…

Read More

Singapore, Singapore, July 15th, 2026, FinanceWire TrustFinance Awards today announced the launch of its Verified Recognition framework as part of TrustFinance Awards 2026, introducing a transparent, structured, and verifiable recognition system designed to strengthen credibility across financial industry awards. The new framework enables organizations to demonstrate that their recognition is supported by a clear evaluation process, addressing the growing demand for greater transparency and trust across the global financial services industry. Trust has become one of the financial industry’s most valuable assets. As clients increasingly look beyond products and pricing,…

Read More

Singapore, Singapore, July 15th, 2026, FinanceWire TrustFinance Awards today announced the launch of its Verified Recognition framework as part of TrustFinance Awards 2026, introducing a transparent, structured, and verifiable recognition system designed to strengthen credibility across financial industry awards. The new framework enables organizations to demonstrate that their recognition is supported by a clear evaluation process, addressing the growing demand for greater transparency and trust across the global financial services industry. Trust has become one of the financial industry’s most valuable assets. As clients increasingly look beyond products and pricing,…

Read More

New York, United States, July 15th, 2026, FinanceWire Atlas Healthcare Fund managed by VST Capital, today highlighted a series of early conviction investment decisions that have defined its track record since launch — none more striking than its position in Eli Lilly and Company, entered at approximately $350 per share in 2020, years before GLP-1 receptor agonists became the most consequential pharmaceutical story of the decade. Eli Lilly now trades above $1,200, a gain of more than 246% from the fund’s entry point. At the time of purchase, Lilly’s tirzepatide…

Read More